Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Romney’s Health Care Advisors Drawn From CMS Trenches

This article was originally published in The Gray Sheet

Executive Summary

Team reunites officials who had served at HHS during the George W. Bush administration.

You may also be interested in...



IPAB Raised At Debate; Romney Advisor Skeptical Board Will Ever Meet, Even If Obama Wins

Strict conflict-of-interest restrictions will make it very challenging to get people confirmed to serve on the Independent Payment Advisory Board, established under health reform, according to a top advisor to Mitt Romney. IPAB was a contentious issue in last week’s presidential debate.

Republican Party Platform Embraces FDA Reform

The call for streamlined and predictable regulation is not surprising, but dedicating space in the platform specifically to point out FDA’s flaws indicates the growing importance and attention the agency commands. The Republican party adopted its official policy platform last week.

Dream Of FDA-CMS Parallel Review May Require New Tack, Suggests Gottlieb

If FDA and CMS want a parallel review process that's palatable to manufacturers, or even agency staffers, they will need to try a new tack, regulatory expert and former FDAer Scott Gottlieb suggests.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel